Want to join the conversation?
Foster City, California-based drug maker $GILD said that the U.S. Food and Drug Administration has approved Odefsey for the treatment of HIV-1 infection. Odefsey is $GILD's second TAF-based regimen to receive FDA approval, and represents the smallest pill of any single tablet regimen for the treatment of HIV.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?